Issue navigation
Volume 18, Issue 3, March 2024
Editorials
Adalimumab: A ‘Maillon Faible’ in the Treatment of Ulcerative Colitis?
Xavier Roblin and Stephane Paul
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 337–338, https://doi.org/10.1093/ecco-jcc/jjad167
Refining the Concept of Microscopic Colitis: HLA Signatures Discriminating Collagenous and Lymphocytic Colitis
Sebastian Bruno Ulrich Jordi and Benjamin Misselwitz
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 339–340, https://doi.org/10.1093/ecco-jcc/jjad211
Original Articles
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study
Sivan Harnik and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 341–348, https://doi.org/10.1093/ecco-jcc/jjad156
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
Tenghao Zheng and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 349–359, https://doi.org/10.1093/ecco-jcc/jjad165
Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients
Alireza Beheshti Maal and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 360–374, https://doi.org/10.1093/ecco-jcc/jjad157
Temporary Faecal Diversion for Refractory Perianal and/or Distal Colonic Crohn’s Disease in the Biologic Era: An Updated Systematic Review with Meta-analysis
Michael Jew and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 375–391, https://doi.org/10.1093/ecco-jcc/jjad159
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases
Boldizsár Jójárt and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 392–405, https://doi.org/10.1093/ecco-jcc/jjad160
Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial
Raja Atreya and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 406–415, https://doi.org/10.1093/ecco-jcc/jjad162
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn’s Disease in a Randomized Phase 3 Trial
Marc Ferrante and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 416–423, https://doi.org/10.1093/ecco-jcc/jjad168
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID
Mathieu Uzzan and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 424–430, https://doi.org/10.1093/ecco-jcc/jjad169
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients
Benjamin Y H Bai and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 431–445, https://doi.org/10.1093/ecco-jcc/jjad166
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases
Simone Weber and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 446–461, https://doi.org/10.1093/ecco-jcc/jjad164
Review Articles
Matrix metalloproteinases in intestinal fibrosis
Carin Biel and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 462–478, https://doi.org/10.1093/ecco-jcc/jjad178
Patient-reported Outcome Measures in Ileoanal Pouch Surgery: a Systematic Review
Zakary Ismail Warsop and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 479–487, https://doi.org/10.1093/ecco-jcc/jjad163
Short Report
Mitigating the Risk of Tofacitinib-induced Adverse Events in the Elderly Population with Ulcerative Colitis
Anna Viola and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Pages 488–491, https://doi.org/10.1093/ecco-jcc/jjad158
Letter to the Editor
6-Mercaptopurine in ulcerative colitis: the potential of upfront dosing with allopurinol
Steven Trinh and others
Journal of Crohn's and Colitis, Volume 18, Issue 3, March 2024, Page 492, https://doi.org/10.1093/ecco-jcc/jjad150
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals